Histone deacetylase inhibition ameliorates kidney injury by restoring fibroblast features to myofibroblasts
Life Sciences · 2026-10 · 402 · 124599
DOI: 10.1016/j.lfs.2026.124599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2026-10. Verfasst von Hirotaka Ishioka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Applied Oxygen Physiology Project, New Industry Creation Hatchery Center, Tohoku University, Sendai, Japan; Division of Oxygen Biology, Tohoku Univer…. Hauptthemen laut MEDLINE: Myofibroblasts, Histone Deacetylase Inhibitors, Fibroblasts, Renal Insufficiency, Chronic. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Suzuken Memorial Foundation, Takeda Science Foundation, The Uehara Memorial Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Applied Oxygen Physiology Project, New Industry Creation Hatchery Center, Tohoku University, Sendai, Japan; Division of Oxygen Biology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Nephrol…
- Applied Oxygen Physiology Project, New Industry Creation Hatchery Center, Tohoku University, Sendai, Japan; Division of Oxygen Biology, Tohoku University Graduate School of Medicine, Sendai, Japan.
- Division of Oxygen Biology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Nephrology, Juntendo University, Tokyo, Japan.
- Department of Nephrology, Tohoku University Graduate School of Medicine, Sendai, Japan.
- Applied Oxygen Physiology Project, New Industry Creation Hatchery Center, Tohoku University, Sendai, Japan; Division of Oxygen Biology, Tohoku University Graduate School of Medicine, Sendai, Japan. Electronic address: n…
Förderung
- Suzuken Memorial Foundation
- Takeda Science Foundation
- The Uehara Memorial Foundation
- Tohoku University The Frontier Research Institute for Interdisciplinary Sciences
- Naito Foundation
- Astellas Foundation for Research on Metabolic Disorders
- Senshin Medical Research Foundation
- Japan Agency for Medical Research and Development
Zitieren
APA
Ishioka, H., Iwamura, Y., Konta, Y., Sato, K., Kato, K., Tanaka, T., Nakai, T., & Suzuki, N. (2026). Histone deacetylase inhibition ameliorates kidney injury by restoring fibroblast features to myofibroblasts. Life Sciences, 402, 124599. https://doi.org/10.1016/j.lfs.2026.124599
Vancouver
Ishioka H, Iwamura Y, Konta Y, Sato K, Kato K, Tanaka T, et al. Histone deacetylase inhibition ameliorates kidney injury by restoring fibroblast features to myofibroblasts. Life Sciences. 2026;402:124599. doi:10.1016/j.lfs.2026.124599
BibTeX
@article{Ishioka2026,
author = {Ishioka, Hirotaka and Iwamura, Yuma and Konta, Yusuke and Sato, Koji and Kato, Koichiro and Tanaka, Tetsuhiro and Nakai, Taku and Suzuki, Norio},
title = {Histone deacetylase inhibition ameliorates kidney injury by restoring fibroblast features to myofibroblasts},
journal = {Life Sciences},
year = {2026},
volume = {402},
pages = {124599},
doi = {10.1016/j.lfs.2026.124599}
}
EUVIMED